David D. O'Toole
Known title: CFOCIK: 0001491140
David D. O'Toole's purchase track record
How the stock did after each of David D. O'Toole's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
13
of 14 since June 20, 2023
Stock higher 6 months later
31%
3 months: 36%
Median 6-month return
-20.3%
3 months: -10.9%
Beat the S&P 500
31%
median -29.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/19/2026 | RCEL | $17K | +133.9% | pending | — |
| 3/11/2026 | RCEL | $9K | -14.2% | +111.7% | +12.7% |
| 2/19/2026 | RCEL | $12K | +2.3% | +130.1% | +11.4% |
| 8/26/2025 | RCEL | $9K | -17.8% | +18.2% | +6.6% |
| 8/12/2025 | RCEL | $10K | -28.3% | -27.5% | +7.7% |
| 2/19/2025 | RCEL | $20K | -36.2% | -54.1% | +4.1% |
| 12/5/2024 | RCEL | $12K | -33.5% | -53.8% | -2.2% |
| 5/30/2024 | RCEL | $9K | -2.0% | +37.9% | +15.2% |
| 2/28/2024 | RCEL | $22K | -47.8% | -46.0% | +10.3% |
| 12/12/2023 | RCEL | $12K | +38.6% | -26.7% | +15.8% |
| 12/1/2023 | RCEL | $5K | +60.7% | -14.5% | +14.9% |
| 11/14/2023 | RCEL | $71K | +26.2% | -35.1% | +16.7% |
| 8/15/2023 | RCEL | $124K | -23.8% | -3.8% | +11.6% |
| 6/20/2023 | RCEL | $16K | -7.6% | -20.3% | +8.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| RCEL | ▲ Buy | Grant | 2,000 | $8K | 6/12/2026 | View on chart |
| RCEL | ▲ Buy | Grant | 5,000 | $15K | 5/29/2026 | View on chart |
| RCEL | ▲ Buy | Open Market | 2,000 | $9K | 5/20/2026 | View on chart |
| RCEL | ▲ Buy | Open Market | 2,000 | $8K | 5/19/2026 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,800 | $9K | 3/11/2026 | View on chart |
| RCEL | ▲ Buy | Open Market | 3,000 | $12K | 2/19/2026 | View on chart |
| RCEL | ▲ Buy | Grant | 105,470 | — | 2/18/2026 | View on chart |
| RCEL | ▲ Buy | Open Market | 2,000 | $9K | 8/26/2025 | View on chart |
| RCEL | ▲ Buy | Open Market | 2,000 | $10K | 8/12/2025 | View on chart |
| RCEL | ▲ Buy | Grant | 1,923 | $9K | 5/30/2025 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $10K | 2/20/2025 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $10K | 2/19/2025 | View on chart |
| RCEL | ▲ Buy | Open Market | 475 | $6K | 12/5/2024 | View on chart |
| RCEL | ▲ Buy | Open Market | 500 | $6K | 12/5/2024 | View on chart |
| RCEL | ▲ Buy | Grant | 785 | $6K | 11/29/2024 | View on chart |
| RCEL | ▲ Buy | Grant | 2,240 | $18K | 5/31/2024 | View on chart |
| RCEL | ▲ Buy | Open Market | 500 | $5K | 5/30/2024 | View on chart |
| RCEL | ▲ Buy | Open Market | 500 | $4K | 5/30/2024 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $17K | 2/28/2024 | View on chart |
| RCEL | ▲ Buy | Open Market | 250 | $4K | 2/28/2024 | View on chart |
| RCEL | ▲ Buy | Open Market | 950 | $12K | 12/12/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 500 | $5K | 12/1/2023 | View on chart |
| RCEL | ▲ Buy | Grant | 1,034 | $9K | 11/30/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $10K | 11/21/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $10K | 11/21/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $12K | 11/16/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $12K | 11/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $13K | 11/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $13K | 11/14/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $17K | 8/16/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $17K | 8/16/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $18K | 8/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $18K | 8/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $18K | 8/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $18K | 8/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $18K | 8/15/2023 | View on chart |
| RCEL | ▲ Buy | Open Market | 1,000 | $16K | 6/20/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
RCEL Gains Fair Value Lift After PermeaDerm Data and Q2 Beat
PermeaDerm data and a Q2 earnings beat lifted RCEL’s fair value. The news gave the stock a positive momentum boost. The lift comes as the company reports stronger‑than‑expected results and promising data from its PermeaDerm platform. The move is a short‑term reaction to the earnings beat and data release.
RCEL Gains Fair Value Lift After PermeaDerm Data and Q2 Beat. PermeaDerm data and a Q2 earnings beat lifted RCEL’s fair value. The news gave the stock a positive momentum boost. The lift comes as the company reports stronger‑than‑expected results and promising data from its PermeaDerm platform. The move is a short‑term reaction to the earnings beat and data release.